The clinical and cost effectiveness of the use of brachytherapy to treat breast cancer
Kelly J, Thompson L
Record ID 32013000458
English
Authors' recommendations:
NICE guidance states that brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision raises no major safety concerns, although the limited evidence on efficacy means that this procedure should only be used in the context of research. It should be noted that this guidance is based on evidence up to 2007. Two large randomised studies are currently in progress in the USA and Europe.
No systematic review or randomised trial evidence was identified on the use of boost brachytherapy as an adjunct to conventional whole breast irradiation following surgery for breast cancer.
More work on clinical effectiveness is needed before conclusions can be drawn on cost effectiveness.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/earlier_evidence_notes/evidence_note_35.aspx
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland, United Kingdom
MeSH Terms
- Brachytherapy
- Cost-Benefit Analysis
Contact
Organisation Name:
Scottish Health Technologies Group
Contact Address:
Scottish Health Technologies Group, Delta House, 50 West Nile Street, Glasgow, G1 2NP Tel: 0141 225 6998
Contact Name:
his.shtg@nhs.scot
Contact Email:
his.shtg@nhs.scot
Copyright:
Healthcare Improvement Scotland
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.